Centennial Surgical Suture Inc Stock Price Today (NSE: CSURGSU)

Centennial Surgical Suture Inc

86.30+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Centennial Surgical Suture Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Centennial Surgical Suture Inc share price today is 86.30, up +0.00% on NSE/BSE as of 18 June 2026. Centennial Surgical Suture Inc (CSURGSU) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of 38.05 (Cr). The 52-week high for CSURGSU share price is 189.00 and the 52-week low is 76.27. The company has a Return on Equity (ROE) of -4.64% and a debt-to-equity ratio of 0.35.

Centennial Surgical Suture Inc Share Price Chart — NSE/BSE Historical Performance

No data
High
105.51
Low
86.30
Volume
113.91666666666667
Change
-5.16%

Centennial Surgical Suture Inc share price chart: -5.16% return over the past month. 52-week high ₹189.00, 52-week low ₹76.27.

Centennial Surgical Suture Inc — Last 10 Trading Days

DateOpenHighLowCloseVolume
90.2090.2086.3086.3011.00 (Cr)
90.2090.2090.2090.2024.00 (Cr)
90.1090.1090.1090.10100.00 (Cr)
89.3393.7489.3393.6576.00 (Cr)
95.7095.7089.3089.32241.00 (Cr)
92.6394.0092.6394.0062.00 (Cr)
93.2397.5093.2397.5040.00 (Cr)
100.00100.2490.7293.23312.00 (Cr)
105.51105.5195.4895.48258.00 (Cr)
100.91100.91100.50100.5017.00 (Cr)

Centennial Surgical Suture Inc — Last 12 Months Price History

MonthOpenHighLowCloseChange
90.2090.2086.3086.30-4.32%
104.20105.5189.3090.20-13.44%
78.90105.3076.3099.25+25.79%
83.50110.0376.2776.27-8.66%
95.80110.0082.8584.55-11.74%
102.80102.8089.9594.00-8.56%
106.65114.5091.20102.80-3.61%
105.80124.9090.00104.85-0.90%
106.75112.9090.00108.00+1.17%
115.00136.50100.30106.80-7.13%
148.00189.00117.55120.00-18.92%
144.50168.00137.30155.50+7.61%

AI Research Briefing

Powered by Gemini · 2026-04-17

Micro-cap MedTech play with weak fundamentals, potential price manipulation, and reliance on industry tailwinds for survival.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEBreakdown. 1M: -3.43%, 3M: -5.65%, 6M: -26.81%P/E is non-existent due to losses. Industry P/E is 47.87x, making it difficult to compare.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Centennial Surgical Suture Ltd. (CSURGSU) has been under pressure, hitting a fresh 52-week low of on March 30, 2026. This was the fifth consecutive session of losses, marking a 12.32% decline over those five days. The company also reported unusual price movement and alleged possible price rigging, requesting a BSE/SEBI probe on March 17, 2026. The Exchange sought clarification from the company regarding significant price movement on March 13, 2026.

CORE STORY (THE REAL GAME)

Why Now
  • India MedTech sector projected to reach US$50 billion by 2030
  • Recent allegations of price manipulation raise governance concerns
  • Stock at 52-week low, reflecting weak fundamentals
Potential Catalysts
  • Significant order wins or contract announcements
  • Successful resolution of price manipulation allegations
  • Turnaround in financial performance and profitability
Key Risks
  • Micro/SME cap implies liquidity risk
  • Allegations of price manipulation
  • Declining operating profits (5Y CAGR of -12.72%)
Institutional Activity

No FII/DII activity. Promoter holding stable at 46.89%.

Macro Context

India's medical devices sector has strong growth potential, but import dependence persists.

Order Book / Expansion

No major news found after live search.

Cash Flow Quality

Profit not converting to cash. Free Cash Flow 5Y: ₹10.97 Cr

3–6 Month Outlook

The company's future hinges on capitalizing on the MedTech industry's growth and resolving its fundamental weaknesses. A turnaround is possible, but highly uncertain.

Primary Thesis Risk

Inability to achieve profitability and potential governance failures will kill this stock.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

-4.64%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

3.94%

Returns generated on total capital deployed

Average

Oper. Profit Margin (5Y Avg)

10.71%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Centennial Surgical Suture Inc Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

47.87x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

46.89%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-107.69%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-5.68%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-0.77%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.35x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

0.35x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

10.97 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Centennial Surgical Suture Inc Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CSURGSU across key market metrics for learning purposes.

Positive Indicators

1 factors identified

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (-4.64%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (3.94%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-107.69%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-5.68%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (-0.77% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Interest Coverage (0.35x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Centennial Surgical Suture Inc vs Medical Equipment & Supplies Peers

Peer Comparison - Medical Equipment & Supplies

Compare Centennial Surgical Suture Inc with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
13.5/100
86
₹38.05
-4.64%
Poor
3.94%
Poor
0.3
Excellent
-0.77%
Poor
0.00%
60.7/100
1334
₹19506.20
53.9
Average
15.77%
Good
20.08%
Excellent
0.1
Excellent
28.38%
Excellent
19.44%
Excellent
0.18%
31.7/100
36
₹3162.93
157.5
Average
0.70%
Poor
1.08%
Poor
0.1
Excellent
0.01%
68.7/100
230
₹1488.44
57.8
Average
21.88%
Excellent
19.20%
Good
0.0
Excellent
57.51%
Excellent
9.81%
Good
0.00%
42.1/100
464
₹1363.11
50.1
Average
30.08%
Excellent
31.14%
Excellent
0.6
Good
0.00%
13.8/100
209
₹1224.98
59.6
Average
4.75%
Poor
6.91%
Poor
0.6
Good
0.00%
60.3/100
151
₹633.93
25.8
Average
36.78%
Excellent
31.12%
Excellent
0.5
Good
90.06%
Excellent
61.82%
Excellent
0.00%
68.5/100
389
₹521.17
26.2
Average
18.74%
Good
25.25%
Excellent
0.0
Excellent
29.49%
Excellent
22.80%
Excellent
0.23%
61.2/100
387
₹354.57
34.2
Average
13.58%
Average
16.35%
Good
0.4
Excellent
74.11%
Excellent
13.69%
Good
0.00%
47.7/100
181
₹294.37
32.7
Average
13.56%
Average
18.45%
Good
0.0
Excellent
0.00%
Nureca Ltd...
NURECA543264
36/100
240
₹292.61
71.2
Average
-1.12%
Poor
-0.90%
Poor
0.0
Excellent
1.98%
Average
0.00%

Centennial Surgical Suture Inc PE Ratio History

Historical price-to-earnings ratio for CSURGSU — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20243.11₹138.0044.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Centennial Surgical Suture Inc Quarterly Performance

Latest quarterly metrics for CSURGSU — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-5.68%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-107.69%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-0.77%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Centennial Surgical Suture Inc Technical Indicators

SMA 50, SMA 200, RSI and volume signals for CSURGSU — calculated from daily price history

41RSI 14
Neutral — RSI 41

Momentum is balanced — neither overbought nor oversold.

SMA 50
92
▼ Price below SMA 50 — Short-term bearish
SMA 200
111
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
0K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Centennial Surgical Suture Inc Financial Statements

Annual income statement, balance sheet and cash flow for Centennial Surgical Suture Inc (CSURGSU) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Centennial Surgical Suture Inc

About CSURGSU (Centennial Surgical Suture Inc)

Centennial Surgical Suture Inc. (CSURGSU) is a global provider of premium surgical suture and advanced wound closure solutions for the modern operating room. The company distinguis...hes itself through a commitment to innovation, developing a comprehensive portfolio of products designed to meet the diverse needs of surgeons across various specialties. CSURGSU blends traditional craftsmanship with cutting-edge technology to create sutures that offer superior tensile strength, smooth passage through tissue, and optimal knot security. Their offerings span the spectrum of suture materials, from rapidly absorbable options ideal for delicate tissue repair to robust non-absorbable sutures designed for long-term support. CSURGSU strives to be a trusted partner for surgeons, improving patient outcomes and advancing surgical techniques. CSURGSU's extensive product catalog encompasses a wide range of absorbable and non-absorbable sutures, each engineered for specific surgical applications. Absorbable sutures are crafted with varying absorption profiles, providing surgeons with the flexibility to choose the ideal material for tissue healing rates. The non-absorbable suture line offers permanent support and is available in a variety of materials, including braided polymers, monofilaments, and specialized metal options. Beyond sutures, CSURGSU provides a suite of complementary wound closure devices, including surgical meshes, surgical staplers, and tissue adhesives. These devices complement their suture lines and enables surgeons to create effective and efficient wound closures. Underpinning CSURGSU's product innovation is a dedication to quality and regulatory compliance. The company operates state-of-the-art manufacturing facilities that adhere to the highest international standards. Rigorous quality control procedures are implemented throughout the entire manufacturing process, from raw material sourcing to final product packaging. This ensures that every CSURGSU suture meets or exceeds the expectations of surgeons and regulatory bodies. Moreover, CSURGSU fosters a culture of continuous improvement, constantly seeking opportunities to enhance its products, processes, and customer service. This commitment to excellence has established CSURGSU as a reliable and respected name in surgical suture technology.

Company Details

Symbol:CSURGSU
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Vijay Kalidas Majrekar B.Com, M.B.A.
Chairman, CEO & MD
Ms. Anuradha Raghunandan Kashikar
CFO & Whole Time Executive Director
Ms. Mahima Bathwal
Company Secretary & Compliance Officer

CSURGSU Share Price: Frequently Asked Questions

What is the current share price of Centennial Surgical Suture Inc?

Centennial Surgical Suture Inc (CSURGSU) trades at ₹86.30 on NSE and BSE. Market cap ₹38.05 (Cr). Educational data only.

What is the P/E ratio of Centennial Surgical Suture Inc?

Centennial Surgical Suture Inc has a P/E of N/Ax vs industry average 47.87x.

What is the Bull Run score for Centennial Surgical Suture Inc?

Centennial Surgical Suture Inc has a Bull Run score of 13.5/100 based on 25+ financial parameters.

Does Centennial Surgical Suture Inc pay dividends?

Centennial Surgical Suture Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Centennial Surgical Suture Inc?

Centennial Surgical Suture Inc has ROE of -4.64%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Centennial Surgical Suture Inc?

Centennial Surgical Suture Inc has debt-to-equity of 0.35.

Is Centennial Surgical Suture Inc a good investment?

Bull Run gives Centennial Surgical Suture Inc a score of 13.5/100. This is not investment advice — consult a SEBI-registered advisor.